Decarboxylated Cannabinoid Compositions With Low-Thermal Degradation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing methods for decarboxylating cannabinoids in industrial hemp and cannabis result in thermal degradation products and undesirable chemical modifications, necessitating improved decarboxylation processes.

Innovation Solution

Development of compositions comprising decarboxylated cannabinoids and additional components like cellulose I, produced through improved decarboxylation methods, which maintain the stability of cannabinoids and minimize thermal degradation.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If prolonged heating is used for decarboxylation, then decarboxylation efficiency is improved, but thermal degradation products increase

Engineering Contradiction:
Improvedecarboxylation efficiencyVSAvoidthermal degradation products
Core Design Contradiction:
ProductivityVSObject-generated harmful factors

Solution Approach 1:

The patent applies parameter changes by modifying the decarboxylation process conditions - specifically using lower temperatures combined with extended time periods, or alternative energy inputs (microwave, ultrasound) to achieve decarboxylation without the high-temperature conditions that cause thermal degradation. This transforms the traditional high-temperature short-time process into a low-temperature extended-time process, resolving the contradiction between efficiency and degradation.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent substitutes traditional thermal heating mechanisms with alternative energy fields such as microwave radiation or ultrasound. This replacement allows decarboxylation to occur through non-thermal or reduced-thermal mechanisms, achieving the desired chemical transformation while minimizing the thermal degradation that plagues conventional heating methods.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

2Manufacturing precision

If conventional decarboxylation methods are used, then cannabinoid conversion is achieved, but undesirable chemical modifications occur

Engineering Contradiction:
Improvecannabinoid conversionVSAvoidundesirable chemical modifications
Core Design Contradiction:
Manufacturing precisionVSObject-generated harmful factors

Solution Approach 1:

The patent employs inert or controlled atmospheric conditions during decarboxylation to prevent unwanted chemical reactions. By excluding oxygen or controlling the gaseous environment, the process achieves complete cannabinoid conversion while preventing oxidation and other undesirable chemical modifications that would occur in conventional open-system heating.

Inventive Principle:
Principle #39Inert atmosphere (Inert environment)

Solution Approach 2:

The patent replaces conventional thermal processing with alternative energy mechanisms (microwave, ultrasound, or enzymatic catalysis) that enable precise cannabinoid conversion without the uncontrolled chemical side reactions associated with traditional high-temperature heating methods.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The compositions preserve the efficacy of cannabinoids while reducing thermal degradation, enabling their use in dietary supplements and pharmaceuticals.

Implementation Method 1

The biosynthesis of cellulose results in cellulose I, which is metastable, and cellulose I irreversibly converts to other forms of cellulose that are commonly used in commercial applications.

Methodology Applied
Scientific EffectMetastability: Metastability

Data Source

PatentUS12582663B2Compositions comprising decarboxylated cannabinoids
Publication Date: 2026.03.24 NATURAL EXTRACTION SYSTEMS LLC

AI summary

Various aspects of this disclosure relate to compositions comprising (i) one or more decarboxylated cannabinoids and (ii) either (a) cellulose I, (b) nucleic acids that comprise one or more nucleotide sequences that encode a geranyl-pyrophosphate-olivetolic acid geranyltransferase, (c) protein that comprises one or more amino acid sequences that encode a geranyl-pyrophosphate-olivetolic acid geranyltransferase, (d) two of a, b, and c, or (e) each of a, b, and c.